CompuGroup Medical SE KgaA (XTER:COP) Other Net Income (Loss) : €0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is CompuGroup Medical SE KgaA Other Net Income (Loss)?

CompuGroup Medical SE KgaA's Other Net Income (Loss) for the three months ended in Mar. 2024 was €0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was €0 Mil.

CompuGroup Medical SE KgaA Other Net Income (Loss) Historical Data

The historical data trend for CompuGroup Medical SE KgaA's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CompuGroup Medical SE KgaA Other Net Income (Loss) Chart

CompuGroup Medical SE KgaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

CompuGroup Medical SE KgaA Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

CompuGroup Medical SE KgaA Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

CompuGroup Medical SE KgaA Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of CompuGroup Medical SE KgaA's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

CompuGroup Medical SE KgaA (XTER:COP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CompuGroup Medical SE & Co KgaA (XTER:COP) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

CMPUY:USA COPd:UK 0MSD:UK COP:Austria

Address

Maria Trost 21, Koblenz, DEU, 56070

Website

https://www.cgm.com

CompuGroup Medical SE & Co KgaA provides electronic health solutions to healthcare providers through four segments: Ambulatory information systems, Pharmacy information systems, Hospital information systems, and Consumer and Health Management Information Systems. The Ambulatory information systems segment contributes to the majority of revenue and provides practice management software and electronic medical record management. Pharmacy information systems provide clinical, administrative, and financial software for retail pharmacies. The Hospital information systems segment sells its solutions to in-patient centers. Consumer and Health Management Information Systems offers networking service connect providers and other market participants.

Executives

Michael Rauch	Managing director of the general partner of the issuer
Emanuele Mugnani	Managing director of the general partner of the issuer
Frank Gotthardt	Chairman of Administrative Board of CompuGroup Medical Management SE
Prof. (apl.) Dr. Med Daniel Gotthardt	Member of the Administrative Board of CompuGroup Medical Management SE
Hannes Reichl	Managing director of the general partner of the issuer
Dr. Eckart Pech	Managing director of the general partner of the issuer
Dr. Dirk Wössner	CEO, Managing director of the general partner of the issuer
Dr. Ralph Körfgen	Managing director of the general partner of the issuer